Oral Cancer Foundation

“No review was or will be conducted.”

“Compensation of ceo is subject to the approval of independent board members.”

“Governing documents are available upon request.”

“Ocf 2022 990 narrative 2022 continued many of the pandemic issues, and for at least half the year was a repeat for many small nonprofit entities including ocf. National focus for charitable giving decreased across the board, many quality small nonprofits, and small businesses closed their doors for good according to the journal of philanthropy, and ocf's base of donors drawn largely from the middle class had less free income for things like donations to charities and were also fighting the inflation that impacted their personal economic status. All this impacted us in significant ways. While we had some cash reserves, we had to dial back many programs, and reduce staff. As stated in 2020, a year before the pandemic, ocf had already adopted a work from home model, and had reduced overhead costs by eliminating office spaces. Again in 2022, all of our fundraising and awareness events where people gathered in person had to be cancelled in accordance with cdc guidelines, up until the last three months of the year. Those historically bring in 65% of our operating budget. Writing this in 2023, we saw things about the same with limited events, but with a vaccine and a more vaccinated population, we are optimistic about the future, and our ability to get back to awareness events that help generate visibility and donations to the foundation is as this is being written, turning around the financial situation for 2023. Cancer has not gone away during the covid crisis. 2 million americans still were diagnosed with it in 2022 and about 660,000 died from it. That part of the world did not change. The demands for our services stayed the same as in the previous years, but we continued to work longer hours with fewer staff to address the volume of patient centric help requests that came in. In essence we are still standing and doing good in the world even with the many negatives that 2020-2022 placed on us. The foundations' public outreach and disseminating actionable information missions stayed strong. This was facilitated by increased visibility of the foundation through an organic spread of our large internet presence. A major rebuild of our internet presence was begun in the last quarter of 2014, but annually we have added to our satellite web sites on oral cancer that access current and archived news stories about our disease, and a separate educational site for the public on self-screening techniques for early discovery and self-referral of suspect tissues in their oral environment to name a couple. This mobile friendly move accelerated public engagement with the disease and the foundation. Ocf continues to have few corporate pharma sponsors, and we did not have that resource to fall back on like some other nonprofits that survive on pharma and medical society grants. It should be stated that unlike other nonprofits in our space we do not take much pharma money nor apply for it. We choose to keep our dependence on that industry to a minimum and there is a perception of the influences they can have on nonprofits that is not always positive. The foundation's public outreach efforts continued to focus heavily on the role of the hpv virus as an oral cancer cause, and how common infection with it is in the us. Ocf staff members and key opinion/science leaders allied with ocf spoke virtually at numerous events on hpv and vaccination. We have continued last year's effort to increase speaking engagements in the dental community, as they are becoming an important part of the early discovery paradigm and education of the public on hpv, even if the platform to do so has changed. In 2022 these ideas began to move to in person versus virtual lectures and meetings. Our volunteer rdh advisory board continues to be an important part of accomplishing this outreach with many of them presenters at professional meetings on the importance of proper screening for these cancers. There is a great deal of misinformation about the hpv virus and the relative risk t”

“Web content 41,000 0 0 professional relations 3,600 0 0 consulting special projects 8,475 0 0 pr release 2,570 0 0 total 55,645 0 0”